| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 38.7269 | 4 |
| GSM780708 | Untreated after 4 days (C2_1) | 39.2763 | 5 |
| GSM780709 | Untreated after 4 days (C3_1) | 44.4089 | 24 |
| GSM780719 | Untreated after 4 days (C1_2) | 34.769 | 1 |
| GSM780720 | Untreated after 4 days (C2_2) | 38.2626 | 3 |
| GSM780721 | Untreated after 4 days (C3_2) | 33.7129 | 1 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 37.9513 | 2 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 40.4161 | 8 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 35.8958 | 1 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 41.7752 | 12 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 36.0947 | 1 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 35.9739 | 1 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 39.402 | 5 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 40.2658 | 7 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 35.83 | 1 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 39.9585 | 6 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 41.3242 | 11 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 33.3945 | 1 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 42.2718 | 14 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 35.1333 | 1 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 45.7108 | 31 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 38.082 | 3 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 36.1112 | 1 |